Table 2. Clinical descriptive data for patient groups.

		Recent-Onset	Chronic	p
N		16	19
Medication
	Unmedicated	5	2	ns
	Typical Antipsychotic	0	7a	*
	Atypical Antipsychotic	11	13a	ns
	Antidepressant	6	9	ns
Onset Age		22.1(4.2)	24.4(6.5)	*
Duration (yrs.)		.8(.92)b	15.8(7.3)c	***
GAF
	Total	55.2(10.0)	53.6(12.0)	ns
SAPS
	Delusions	.52(.53)	1.02(.76)	ns
	Hallucinations	.67(.85)	.98(1.0)	ns
	Thought Disorder	.27(.50)	.75(.90)	**
	Bizarre Behaviour	.47(.58)	.43(.58)	ns
	Total	.48(.35)	.86(.61)	**
SANS
	Alogia	1.21(.89)	.91(1.0)	ns
	Affective Flattening	1.51(.81)	1.71(1.3)	ns
	Inappropriate Affect	.80(1.0)	1.21(1.2)	ns
	Avolition	2.22(.88)	2.25(1.2)	ns
	Anhedonia	2.09(1.1)	2.17(1.5)	ns
	Attention	1.31(1.5)	1.35(1.4)	ns
	Total	1.63(.75)	1.67(.87)	ns

Clinical assessments for patient groups. Medication status and mean (SD) of Age, Duration of Illness, SAPS, SANS and GAF scores. SAPS and SANS scores are scaled to a maximum symptom severity of 5. GAF scores reflect percentage of optimal functioning. Last column contains P values obtained from a t-test or chi-squared analysis, as appropriate, comparing recent-onset to chronic groups.

* p<.05;

** p<.01;

*** p<.001; ns Not Significant.

^aThree individuals were taking both typical and atypical antipsychotic medication.

^bRange 0.2 to 2 years.

^cRange 5 to 29 years.